 |
Monica Heger tracks trends in next-generation sequencing for research and clinical applications for GenomeWeb's In Sequence and Clinical Sequencing News. E-mail Monica Heger or follow her GenomeWeb Twitter accounts at @InSequence and @ClinSeqNews. |
Will Qiagen Acquisition of IBS Impact Patent Dispute with Illumina?
July 10, 2012
Will Qiagen Acquisition of IBS Impact Patent Dispute with Illumina?
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Mergers and Acquisitions — Both Successful and Failed — Dominated the NGS World in 2012
January 2, 2013 / In Sequence - Illumina Countersues IBS, Qiagen for Infringement of Sequencing Patents
July 23, 2012 / GenomeWeb Daily News - Azco Sues Qiagen and IBS for Breach of Contract, Fraud over Qiagen's IBS Acquisition
October 29, 2012 / In Sequence - Helicos Considers Next Moves as Remaining Patent in Illumina Suit Is Deemed Invalid
September 4, 2012 / In Sequence - Helicos Licenses Patents to Intelligent Bio-Systems for $1.6M
August 7, 2012 / GenomeWeb Daily News